ITMI20071267A1 - Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative - Google Patents
Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferativeInfo
- Publication number
- ITMI20071267A1 ITMI20071267A1 IT001267A ITMI20071267A ITMI20071267A1 IT MI20071267 A1 ITMI20071267 A1 IT MI20071267A1 IT 001267 A IT001267 A IT 001267A IT MI20071267 A ITMI20071267 A IT MI20071267A IT MI20071267 A1 ITMI20071267 A1 IT MI20071267A1
- Authority
- IT
- Italy
- Prior art keywords
- conjugates
- hyaluronic acid
- skin diseases
- local treatment
- hyperproliferative skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6955—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a plaster, a bandage, a dressing or a patch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001267A ITMI20071267A1 (it) | 2007-06-22 | 2007-06-22 | Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative |
| JP2010512804A JP2010530869A (ja) | 2007-06-22 | 2008-06-19 | 過剰増殖性皮膚疾患の局所治療におけるヒアルロン酸のコンジュゲートの使用 |
| EP08776311A EP2167134B1 (en) | 2007-06-22 | 2008-06-19 | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| ES08776311T ES2394127T3 (es) | 2007-06-22 | 2008-06-19 | Uso de conjugados del ácido hialurónico en el tratamiento local de enfermedades hiperproliferativas de la piel |
| US12/666,286 US9283284B2 (en) | 2007-06-22 | 2008-06-19 | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| AU2008269431A AU2008269431B2 (en) | 2007-06-22 | 2008-06-19 | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| CA2692191A CA2692191C (en) | 2007-06-22 | 2008-06-19 | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| PCT/IB2008/001706 WO2009001209A1 (en) | 2007-06-22 | 2008-06-19 | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| PT87763116T PT2167134E (pt) | 2007-06-22 | 2008-06-19 | Uso de conjugados de ácido hialurónico no tratamento local de doenças de pele hiperproliferativas |
| CN2008801013571A CN101835495B (zh) | 2007-06-22 | 2008-06-19 | 透明质酸结合物在局部治疗过度增殖皮肤病中的应用 |
| IL202875A IL202875A (en) | 2007-06-22 | 2009-12-21 | Use of Hyaluronic Acid Conjugates or History and Anti-Malignant Medications for Topical Treatment of Actinic Radiation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001267A ITMI20071267A1 (it) | 2007-06-22 | 2007-06-22 | Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITMI20071267A1 true ITMI20071267A1 (it) | 2008-12-23 |
Family
ID=39938375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT001267A ITMI20071267A1 (it) | 2007-06-22 | 2007-06-22 | Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9283284B2 (it) |
| EP (1) | EP2167134B1 (it) |
| JP (1) | JP2010530869A (it) |
| CN (1) | CN101835495B (it) |
| AU (1) | AU2008269431B2 (it) |
| CA (1) | CA2692191C (it) |
| ES (1) | ES2394127T3 (it) |
| IL (1) | IL202875A (it) |
| IT (1) | ITMI20071267A1 (it) |
| PT (1) | PT2167134E (it) |
| WO (1) | WO2009001209A1 (it) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1399351B1 (it) | 2009-06-16 | 2013-04-16 | Fidia Farmaceutici | Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi |
| WO2016071365A1 (en) | 2014-11-03 | 2016-05-12 | Spherium Biomed, S.L. | Topical pharmaceutical compositions of paclitaxel |
| WO2016191850A1 (en) * | 2015-05-29 | 2016-12-08 | Aluron Biopharma Inc. | Cross-linked hyaluronic acid for drug delivery and pharmaceutical preparation using same |
| BR112018005200A2 (pt) | 2015-09-16 | 2018-10-09 | Dfb Soria Llc | liberação de nanopartículas de fármaco e métodos de uso dos mesmos |
| CA3056395C (en) | 2017-03-15 | 2022-06-28 | Dfb Soria, Llc | Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes |
| WO2018170207A1 (en) * | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of skin keratoses using nanoparticles of taxanes |
| WO2019178024A1 (en) | 2018-03-16 | 2019-09-19 | Dfb Soria, Llc | Topical therapy for the treatment of cervical intraepithelial neoplasia (cin) and cervical cancer using nanoparticles of taxanes |
| CN109078192B (zh) * | 2018-08-30 | 2021-07-16 | 中山大学 | 一种小肠靶向吸收、生物降解的糖原衍生物、其制备方法及其负载茶多糖的纳米粒 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO169637C (no) | 1983-10-11 | 1992-07-22 | Fidia Spa | Fremgangsmaate for fremstilling av terapeutisk aktive hyaluronsyre-fraksjoner |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
| US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
| IT1263393B (it) | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare |
| ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| DK0971961T3 (da) | 1997-04-04 | 2003-03-24 | Fidia Advanced Biopolymers Srl | N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling |
| ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
| US20040127470A1 (en) * | 1998-12-23 | 2004-07-01 | Pharmacia Corporation | Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| IT1317359B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e |
| IT1317358B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Derivati cross-linkati dell'acido ialuronico. |
| ITPD20020271A1 (it) * | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati. |
| US20070149618A1 (en) * | 2004-02-17 | 2007-06-28 | Action Medicines, S.L. | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| ITPD20050242A1 (it) * | 2005-08-03 | 2007-02-04 | Fidia Farmaceutici | Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico |
-
2007
- 2007-06-22 IT IT001267A patent/ITMI20071267A1/it unknown
-
2008
- 2008-06-19 US US12/666,286 patent/US9283284B2/en active Active
- 2008-06-19 CA CA2692191A patent/CA2692191C/en active Active
- 2008-06-19 EP EP08776311A patent/EP2167134B1/en active Active
- 2008-06-19 WO PCT/IB2008/001706 patent/WO2009001209A1/en active Application Filing
- 2008-06-19 ES ES08776311T patent/ES2394127T3/es active Active
- 2008-06-19 CN CN2008801013571A patent/CN101835495B/zh active Active
- 2008-06-19 JP JP2010512804A patent/JP2010530869A/ja active Pending
- 2008-06-19 AU AU2008269431A patent/AU2008269431B2/en not_active Ceased
- 2008-06-19 PT PT87763116T patent/PT2167134E/pt unknown
-
2009
- 2009-12-21 IL IL202875A patent/IL202875A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2692191A1 (en) | 2008-12-31 |
| JP2010530869A (ja) | 2010-09-16 |
| ES2394127T3 (es) | 2013-01-22 |
| EP2167134A1 (en) | 2010-03-31 |
| CN101835495B (zh) | 2012-03-14 |
| US20100204175A1 (en) | 2010-08-12 |
| AU2008269431B2 (en) | 2013-03-07 |
| CN101835495A (zh) | 2010-09-15 |
| US9283284B2 (en) | 2016-03-15 |
| AU2008269431A1 (en) | 2008-12-31 |
| WO2009001209A8 (en) | 2009-03-26 |
| EP2167134B1 (en) | 2012-08-29 |
| PT2167134E (pt) | 2012-12-11 |
| CA2692191C (en) | 2016-01-05 |
| IL202875A (en) | 2016-02-29 |
| WO2009001209A1 (en) | 2008-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI20071267A1 (it) | Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative | |
| HK1153926A1 (en) | Purin derivatives for use in the treatment of fab-related diseases fab- | |
| ZA201000075B (en) | Purin derivatives for use in the treatment of fab-related diseases | |
| ZA201109384B (en) | Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases | |
| EP1942981A4 (en) | DISTRIBUTION OF MEDIUM TO TISSUE | |
| BR112012004546A2 (pt) | "terapêutica por proteínas ligantes dll4-ligantes" | |
| IL208926A0 (en) | Use of epothelone d in treating tau-associated diseases including alzheimer's disease | |
| PT2254869T (pt) | Novos derivados de 1-benzil-3-hidroximetilindazole e suas utilizações no tratamento de doenças com base na expressão de cx3cr1 e p40 | |
| BR112012001344A2 (pt) | derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças | |
| ITPD20050056A1 (it) | Derivati ammidici del'acido ialuronico in osteoartrosi | |
| HK1148271A1 (zh) | -苄基- -羥基甲基吲唑衍生物及其在治療基於 表達的疾病中的用途 | |
| SI2148667T1 (sl) | Uporaba derivatov cikloheksanheksola pri zdravljenju okularnih bolezni | |
| DK3211005T3 (da) | Terapeutisk anvendelse af specifik ligand i msrv-associerede sygdomme | |
| HK1132919A1 (en) | Use of chitosans for the treatment of nail inflammatory diseases | |
| IL203130A (en) | Variants of 44 cd splicing products for the diagnosis and treatment of neurodegenerative diseases | |
| FI20095600A (fi) | Koostumus ihosairauksien hoitoa varten | |
| FR2934267B1 (fr) | Derives aminophosphiniques utiles dans le traitement de la douleur | |
| IT1396468B1 (it) | Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie. | |
| BRPI0714318A2 (pt) | Utilização de 2-benzoil-imidazopiridinas em terapêutica | |
| BRPI0817483A2 (pt) | uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor | |
| DK2173366T3 (da) | Anvendelse af bigift til behandling af parkinson's sygdom | |
| IT1393945B1 (it) | Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche | |
| BRPI0923886A2 (pt) | "uso de cloreto de amônio em terapia" | |
| BRPI1008188A2 (pt) | "derivados de 6-(6-nh-subistituído-triazolopiridazina-sulfanil) benzotiazóis e benzimidazóis: preparo, aplicação como medicamentos e utilização como inibidores de met" | |
| HK1158954A1 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases |